Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
06/05/20188:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
06/05/20186:00AMGlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2018 and Operational ProgressNASDAQ:SMMTSummit Therapeutics Inc
06/01/20186:00AMGlobeNewswire Inc.Summit Therapeutics Provides Notice of Financial Results for the First Quarter Ended 30 April 2018NASDAQ:SMMTSummit Therapeutics Inc
05/30/20185:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SMMTSummit Therapeutics Inc
05/15/20183:49PMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:SMMTSummit Therapeutics Inc
05/15/20183:44PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
05/09/201812:59PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
05/03/20183:41PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
04/24/20184:28PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
04/23/20186:00AMGlobeNewswire Inc.Summit Highlights Discovery of a Series of New Mechanism Antibiotics for the Treatment of Gonorrhoea in Late-Breaking Present...NASDAQ:SMMTSummit Therapeutics Inc
04/23/20185:45AMGlobeNewswire Inc.Award of Share Options and Restricted Stock UnitsNASDAQ:SMMTSummit Therapeutics Inc
04/20/20186:00AMGlobeNewswire Inc.Summit Presents New 24-Week Analyses from PhaseOut DMD at the 2018 American Academy of Neurology Annual MeetingNASDAQ:SMMTSummit Therapeutics Inc
04/19/20186:00AMGlobeNewswire Inc.Summit Completes Dosing of Ezutromid in PhaseOut DMD Clinical TrialNASDAQ:SMMTSummit Therapeutics Inc
04/13/20188:08AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:SMMTSummit Therapeutics Inc
04/11/20183:48PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
04/11/20186:00AMGlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018 and Operational Pr...NASDAQ:SMMTSummit Therapeutics Inc
04/09/20189:01AMGlobeNewswire Inc.Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018NASDAQ:SMMTSummit Therapeutics Inc
04/05/20186:00AMGlobeNewswire Inc.Summit Therapeutics to Present at the H.C. Wainwright Global Life Sciences ConferenceNASDAQ:SMMTSummit Therapeutics Inc
03/28/20186:00AMGlobeNewswire Inc.Summit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual MeetingNASDAQ:SMMTSummit Therapeutics Inc
03/27/20187:42AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
03/27/20186:00AMGlobeNewswire Inc.Summit Therapeutics Announces Placement of £15.0 Million of Ordinary SharesNASDAQ:SMMTSummit Therapeutics Inc
03/14/20186:00AMGlobeNewswire Inc.Summit Highlights Scientific Rigour of its PhaseOut DMD Clinical Trial at MDA Clinical ConferenceNASDAQ:SMMTSummit Therapeutics Inc
03/13/20186:00AMGlobeNewswire Inc.Summit’s Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against Gonorrhoea...NASDAQ:SMMTSummit Therapeutics Inc
03/07/20186:00AMGlobeNewswire Inc.Summit Expands Enrolment in PhaseOut DMD Phase 2 Clinical Trial to Include Planned Additional GroupNASDAQ:SMMTSummit Therapeutics Inc
02/26/20183:46PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
02/26/20186:00AMGlobeNewswire Inc.Summit Announces New Analysis Showing Ezutromid Significantly Reduced Muscle Inflammation in Phase 2 Clinical Trial in DMDNASDAQ:SMMTSummit Therapeutics Inc
02/23/20186:00AMGlobeNewswire Inc.Summit Therapeutics to Participate in 2018 BTIG Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
02/14/20182:03PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SMMTSummit Therapeutics Inc
02/09/20186:00AMGlobeNewswire Inc.Summit Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:SMMTSummit Therapeutics Inc
01/30/201811:41AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT